![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 17/00 | (2006.01) |
A61K 38/47 | (2006.01) | ||
A61K 38/48 | (2006.01) | ||
A61K 38/46 | (2006.01) | ||
A61P 31/04 | (2006.01) |
(11) | Number of the document | 2947100 |
(13) | Kind of document | T |
(96) | European patent application number | 15152332.1 |
Date of filing the European patent application | 2010-01-06 | |
(97) | Date of publication of the European application | 2015-11-25 |
(45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
142718 P | 2009-01-06 | US | |
153279 P | 2009-02-17 | US | |
170856 P | 2009-04-20 | US |
(72) |
Fallon, Joan M., US
Heil, Matthew, US
Fallon, James J., US
|
(73) |
Galenagen, LLC,
411 Theodore Fremd Avenue, Suite 206, Rye, NY 10580,
US
|
(54) | Oral compositions for the treatment or the prevention of infections by E. Coli |
Oral compositions for the treatment or the prevention of infections by E. Coli |